Kate Hockemeyer
LightNews LightNews
kate-hockemeyer.bsky.social
Kate Hockemeyer
@kate-hockemeyer.bsky.social
110 followers 100 following 0 posts
Rad Onc resident @MSKCancerCenter interested in cancer immunology and stress response pathways. MD/PhD at NYU MSTP
Posts Replies Media Videos
Reposted by Kate Hockemeyer
cp-trendsbiochem.bsky.social
Available online - the Spotlight "FN3K: the (un)sweetest kinase" from Viraj Sanghvi @oncolab.bsky.social and colleagues.

#ProteinPhosphorylation #ProteinGlycation #AdvancedGlycationEndProducts #AGE #SBDD

Read it here: authors.elsevier.com/a/1ktQO3S6Gf...
April 17, 2025 at 3:25 PM
Reposted by Kate Hockemeyer
oncolab.bsky.social
Check out our article in @cp-trendsbiochem.bsky.social
highlighting the elegant work by Joshua-Tor lab, @davidlabmsk.bsky.social, and team .Their findings shed light on the structural basis of FN3K function and open doors for targeting glycation-related diseases. @sanniejculbertson.bsky.social
FN3K: the (un)sweetest kinase
Fructosamine 3-kinase (FN3K) mitigates excessive protein glycation by phosphorylating and destabilizing fructosamines, preventing irreversible advance…
www.sciencedirect.com
April 6, 2025 at 4:16 PM